
Mark van Eldijk, business unit director Nanomedicines at Ardena, explores how flow manufacturing can help reshape the production of nanomedicines and offer a scalable and reproducible path from innovation to implementation.
Nanomedicines are revolutionising therapeutic innovation with nanoscale drug delivery systems that enable treatments to interact with the body at a molecular level. This engineering approach can enhance efficacy, precision and patient safety. However, the complexity that makes these medicines so effective also makes them notoriously difficult to manufacture….